The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Naltrexone 50 mg film-coated tablets

Aop Orphan Pharmaceuticals GmbHPA0934/003/001

Main Information

Trade NameNaltrexone 50 mg film-coated tablets
Active SubstancesNaltrexone hydrochloride
Dosage FormFilm-coated tablet
Licence HolderAop Orphan Pharmaceuticals GmbH
Licence NumberPA0934/003/001

Group Information

ATC CodeN07BB Drugs used in alcohol dependence
N07BB04 naltrexone


License statusAuthorised
Licence Issued11/03/2005
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back